L3VLUP
ProSign in

PCVX · AMGN in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

PCVXAMGN
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • PCVX
  • AMGN
0102030202120222023202420252026
Holders and value by quarter
QuarterPCVXAMGN
Q3 20202 holders, $515m16 holders, $16.3bn
Q4 20201 holders, $108m19 holders, $14.0bn
Q1 20211 holders, $84m16 holders, $14.5bn
Q2 20211 holders, $93m23 holders, $13.8bn
Q3 20211 holders, $104m24 holders, $11.6bn
Q4 20212 holders, $103m21 holders, $10.4bn
Q1 20222 holders, $106m23 holders, $9.9bn
Q2 20224 holders, $107m28 holders, $9.7bn
Q3 20225 holders, $140m21 holders, $7.9bn
Q4 202212 holders, $1.2bn24 holders, $9.3bn
Q1 20238 holders, $978m22 holders, $8.4bn
Q2 20238 holders, $1.6bn26 holders, $7.4bn
Q3 20239 holders, $1.8bn26 holders, $8.7bn
Q4 20239 holders, $2.1bn24 holders, $8.4bn
Q1 20249 holders, $2.7bn25 holders, $6.7bn
Q2 202410 holders, $3.1bn20 holders, $8.0bn
Q3 202412 holders, $5.1bn21 holders, $8.8bn
Q4 202411 holders, $3.6bn20 holders, $8.2bn
Q1 20256 holders, $1.8bn25 holders, $12.0bn
Q2 20257 holders, $969m20 holders, $10.2bn
Q3 20259 holders, $940m17 holders, $10.4bn
Q4 20259 holders, $1.8bn19 holders, $18.0bn
Q1 202612 holders, $2.7bn15 holders, $21.4bn
Q2 20268 holders, $2.9bn23 holders, $24.9bn
PCVX

Vaxcyte Inc

Holders
9
Reported value
$940m
Buyers
5
Sellers
5

Breadth 0 among 95 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
AMGN

Amgen Inc

Holders
17
Reported value
$10.4bn
Buyers
8
Sellers
9

Breadth -1 among 95 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q3 2025

Among the 23 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only PCVX (6)

Brevan Howard Capital Management LP, D. E. Shaw & Co., Maverick Capital Ltd, Point72 Asset Management LP, Voloridge Investment Management LLC, Wellington Management Group LLP

Only AMGN (14)

Acadian Asset Management LLC, AllianceBernstein LP, ARK Investment Management LLC, Capital World Investors, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Invesco Ltd, Man Group PLC, Renaissance Technologies LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, Two Sigma Advisers LP, Verition Fund Management LLC

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →